APGE vs VNO · $2.34B cap vs rev $921.3M
Apogee Therapeutics, Inc. Common Stock (APGE) versus VNO (VNO) — a side-by-side from cached financials, not a winner call.
Apogee Therapeutics, Inc. Common Stock (APGE) is a biotechnology company listed on US.
VNO (VNO) common stock.
APGE does not have a complete income-statement cache yet.
Latest reported VNO revenue for 2026-06-30 was $921.3M. Net income was $24.6M. VNO currently screens at market cap $0.
APGE currently screens at market cap $2.34B. VNO currently screens at market cap $0.
Not investment advice. Open the APGE and VNO stock pages for the full models.
Not investment advice.